Lupin gets CDSCO panel nod to study Ranibizumab Dr. Divya Colin7 March 2023 6:00 PM ISTNew Delhi: The drug major Lupin has got the green signal from the Subject Expert Committee (SEC) from the Central Drug Standard Control Organisation...
Lupin Ranibizumab intravitreal injection gets CDSCO Panel nod for Phase IV study Dr. Divya Colin25 Oct 2022 10:45 AM ISTNew Delhi: Pharmaceuticals major Lupin has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Ranibizumab switch from aflibercept in nAMD patients linked to deterioration in visual acuity: Study Dr. Kamal Kant Kohli22 Sept 2022 8:00 PM ISTUSA: Switching from aflibercept to ranibizumab resulted in a reduction in visual acuity and worse anatomic results in patients with neovascular...
CDSCO Panel approves Intas Ranibizumab for new indication: retinopathy of pre maturity in preterm infants Dr. Divya Colin12 Jun 2022 1:18 PM ISTNew Delhi: Considering the fact that the target subjects are infants, the Subject Expert Committee (SEC) functional under Central Drug Standard...
Biogen, Samsung Bioepis launch USFDA approved BYOOVIZ in US Ruchika Sharma5 Jun 2022 9:00 AM ISTBYOOVIZ is the first biosimilar launch in the U.S. under the Biogen and Samsung Bioepis' partnership.
Sun Pharma gets CDSCO committee approval for manufacturing Ranibizumab Susmita Roy16 April 2022 3:22 PM ISTNew Delhi: In a significant development, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO)...
Intas Pharma, Axantia collaborate for Ranibizumab in Middle East Ruchika Sharma5 April 2022 12:20 PM ISTIntas has developed a biosimilar of Lucentis, which is currently under Phase III global trial for submission in major countries including EMA and the...
Lupin gets CDSCO committee approval for marketing Ranibizumab Medical Dialogues Team7 July 2021 5:03 PM ISTNew Delhi: In a major rejoice to drug maker Lupin, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) has...
Hyderabad: ban on cheap anti-cancer drug affects many patients Pooja Bhatia Bhatia26 Feb 2016 12:29 PM ISTThe recent ban by the Central Drugs Standard Control Organisation (CDSCO) on the use of anti-cancer drug Avastin (generic name Bevacizumab) for...
